Clinical trial
Evaluation of the Effect of Levalbuterol on Allergen Induced Airway Inflammation…
NCT00320034 · Hamilton Health Sciences Corporation, Other · Completed
Key facts
| NCT number | NCT00320034 |
|---|---|
| Title | Evaluation of the Effect of Levalbuterol on Allergen Induced Airway Inflammation In Subjects With Atopic Asthma |
| Official title | Double-blind, Crossover, Placebo-controlled Evaluation of the Effect of Levalbuterol (R-albuterol) on Allergen Induced Airway Inflammation In Subjects With Atopic Asthma |
| Lead sponsor | Hamilton Health Sciences Corporation, Other |
| Collaborators | Sumitomo Pharma America, Inc. Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Asthma |
| Intervention type | Drug |
| Interventions | R-albuterol, S-albuterol |
| Enrollment | 15 |
| Start date | Apr 1, 2006 |
| Primary completion | Jun 1, 2008 |
| Completion | Nov 1, 2009 |
| First posted | Apr 27, 2006 |
| Last update posted | Mar 2, 2011 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: